How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study

Show full item record



Permalink

http://hdl.handle.net/10138/319275

Citation

Mononen , N , Pohjanoksa-Mäntylä , M , Airaksinen , M S A & Hämeen-Anttila , K 2020 , ' How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study ' , BMJ Open , vol. 10 , no. 6 , 036526 . https://doi.org/10.1136/bmjopen-2019-036526

Title: How far are we from a medication use process aiming at well-informed adherent patients with long-term medications in Finland? Qualitative study
Author: Mononen, Niina; Pohjanoksa-Mäntylä, Marika; Airaksinen, Marja S. A.; Hämeen-Anttila, Katri
Contributor: University of Helsinki, Division of Pharmacology and Pharmacotherapy
University of Helsinki, Division of Pharmacology and Pharmacotherapy
University of Helsinki, Division of Pharmacology and Pharmacotherapy
Date: 2020
Language: eng
Number of pages: 11
Belongs to series: BMJ Open
ISSN: 2044-6055
URI: http://hdl.handle.net/10138/319275
Abstract: Objective Finland is one of the few countries that has established a national Medicines Information (MI) Strategy. The ultimate goal of the strategy is a well-implemented medication use process resulting in well-informed adherent patients. This study aimed at evaluating the implementation of the strategy 3years after its launch. Design The evaluation applied a pragmatic approach and was conducted by interviewing stakeholders involved in the National MI Network enhancing the MI Strategy's implementation. The network comprises national key stakeholders producing and using MI. Data were deductively analysed according to the medication use process of the MI Strategy using the framework method, complemented with inductively derived categories. Setting National implementation of the MI Strategy throughout the healthcare system after the first operational period (2012-2014) in 2015. Participants The members of the National MI Network (n=79/111, participation rate 71%, representing 42/53 stakeholder organisations). Outcome measures A new conceptual framework was developed based on stakeholders' views on well-implemented actions and actions needing development in the medication use process at (1) infrastructure (macro), (2) healthcare professionals (meso) and (3) patient (micro) levels. Results Medication counselling by community pharmacists was the primary implemented action, followed by physicians' actions while starting a new medication, and advice given by nurses. The major development needs concerned (1) poor access to patient information and its transfer in healthcare, particularly the lack of reconciled medication lists and electronic health records (macro); (2) poorly functioning medication use process in home care and social care units, such as nursing homes (meso); and (3) limited patient involvement in their care (micro). Conclusions Far more actions for development than well-established practices in the medication use process were identified. Major challenges found in this evaluation are considered in the ongoing Rational Pharmacotherapy Action Plan 2018-2022 by the Ministry of Social Affairs and Health.
Subject: health policy
organisation of health services
public health
qualitative research
health services administration & management
MEDICINES INFORMATION
HOME-CARE
INTERVENTIONS
PHARMACISTS
OPPORTUNITIES
CHALLENGES
MANAGEMENT
ERRORS
3141 Health care science
317 Pharmacy
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
e036526.full.pdf 2.569Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record